New research shows that oxytocin, commonly known as the “love hormone” due to association with social behaviors, may also boost spirituality.
Duke investigators have begun to pinpoint a new mechanism behind the popular drug aspirin, highlighting its use in preventing cardiovascular diseases and colorectal cancers.
On the heels of a new funding agreement last June, the Duke-NUS Medical School in Singapore partnership continues to explore innovative medical curriculums.
Long the fodder for cheesy science-fiction movies, mind reading may be less unrealistic than previously thought.
The patient who received the first hand transplant in North Carolina history at Duke Hospital in May is recovering successful. A team led by Dr. Linda Cendales, associate professor of surgery at Duke University School of Medicine and director of the hand transplant program, performed the surgery on May 27 on 54-year-old Rene Chavez, who lost his left hand in a childhood accident at the age of four.
Joseph DeSimone, co-inventor of a new form of three-dimensional printing technology, emphasized the importance of diversity at the Levine Science Research Center Tuesday.
When Dr. Nancy Andrews, dean of the School of Medicine and vice chancellor for academic affairs, steps down next year, she will leave behind a legacy of open collaboration and strong leadership, her peers said.
A new study by the Sullivan Lab suggests that a major breakthrough in better understanding cancer might be hiding in plain sight.
Neither career lawyers nor fresh-faced premeds are excluded from Science, Law & Policy Laboratory, which is beginning its second year exploring science in a law and policymaking setting.
Christine Whitman, former governor of New Jersey and Environmental Protection Agency administrator when President George W. Bush was in office, discussed the importance of nuclear energy at the Sanford School of Public Policy Wednesday.
Durham, North Carolina—Duke has been awarded the IBM Health Corps award and will receive expertise from IBM’s top employees to build a communications infrastructure that will connect and advance community wellness programs. According to IBM Health Corps, “leading global researchers have declared that, for the first time in human history, we have the financial and technical capacity to eliminate key health disparities between lower and higher income nations, preventing nearly 130 million deaths by 2030.” IBM believes that by strategically investing in the research and development of health technology, the private sector can facilitate solutions to health challenges around the word.
After the University announced in May a proposal from Duke Energy to build a new natural gas facility on campus, some students and faculty members have raised concerns about the proposed plant’s impact and a lack of transparency surrounding the initial stages of the facility's planning.
Nobel laureate Paul Modrich spoke to the Duke community Wednesday about both his prize-winning discovery and his current work with DNA mismatch repair mechanisms in bacteria.
A lawsuit filed by a former Duke employee Joseph Thomas claims that Duke faculty and administrators ignored and hid allegations of academic misconduct within the department of pulmonary, allergy, and critical care medicine.
Duke has signed a petition calling for presidential candidates to publicly share and debate their platforms on science and technology policy.
The effects of television violence is hotly contested by parents and educators alike, but a study co-authored by a Duke researcher may impact future discussions.
Two Duke brain researchers were awarded a $1 million grant by the W.M. Keck Foundation, the University announced Wednesday.
Construction is expected to begin shortly on two new mixed-use buildings in downtown Durham, one of which will be occupied by the Duke Clinical Research Institute.
Ingrid Daubechies—a Belgian James B. Duke professor of mathematics and electrical and computer engineering—received a $1.5 million grant from the Simons Foundation, the University announced Monday.
In 1993, the Pediatric Blood and Marrow Transplant Program of Duke Medicine was the first center in the world to perform a transplant using unrelated umbilical cord blood as an alternative donor source for patients who didn’t have a matching donor in their family or in the adult donor registries.
